EPH139 Adverse Events Associated with Enzyme Replacement Therapies Lysosomal Glycogen-Specific Enzyme (GAA) Medications for the Treatment of Pompe Disease

Jun 1, 2024, 00:00 AM
10.1016/j.jval.2024.03.968
https://www.valueinhealthjournal.com/article/S1098-3015(24)01083-0/fulltext
Section Title :
Section Order : 10406
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)01083-0&doi=10.1016/j.jval.2024.03.968
HEOR Topics :
Tags :
Regions :